Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3964)
All Articles published online
|
Aug 21, 2010 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zois CD, Baltayiannis GH, Bekiari A, Goussia A, Karayiannis P, Doukas M, Demopoulos D, Mitsellou A, Vougiouklakis T, Mitsi V, Tsianos EV. Steatosis and steatohepatitis in postmortem material from Northwestern Greece. World J Gastroenterol 2010; 16(31): 3944-3949 [PMID: 20712056 DOI: 10.3748/wjg.v16.i31.3944] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i31/3944.htm |
| Number | Citing Articles |
| 1 |
Verena C. Obmann, Nando Mertineit, Annalisa Berzigotti, Christina Marx, Lukas Ebner, Roland Kreis, Peter Vermathen, Johannes T. Heverhagen, Andreas Christe, Adrian T. Huber, Gianfranco D. Alpini. CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans. PLOS ONE 2018; 13(7): e0199611 doi: 10.1371/journal.pone.0199611
|
| 2 |
Evangelos Chartampilas. Imaging of nonalcoholic fatty liver disease and its clinical utility. Hormones 2018; 17(1): 69 doi: 10.1007/s42000-018-0012-x
|
| 3 |
Levent Doganay, Kamil Ozdil, Mehmet Sokmen. Last Blood Check Before Passing: Does Alcohol Prevent Fibrosis?. American Journal of Gastroenterology 2013; 108(6): 1010 doi: 10.1038/ajg.2013.74
|
| 4 |
Katharina Cichon, Corinna A. Schön. Influences on the amount of intraperitoneal haemorrhage after blunt liver injury. European Journal of Gastroenterology & Hepatology 2012; : 1 doi: 10.1097/MEG.0b013e3283579445
|
| 5 |
D. Kreul, D. Gascho, S. Franckenberg, S. Eggert, B. Fliss, R.A. Kubik-Huch, M.J. Thali, T. Niemann. Postmortem determination of hepatic steatosis. Comparing Rho/Z and fat fraction measurements on dual-energy CT for histological grading: A retrospective analysis. Forensic Imaging 2020; 23: 200422 doi: 10.1016/j.fri.2020.200422
|
| 6 |
Amreen Dinani, Norman Sussman, Mazen Noureddin, Michael Fuchs, George Therapondos, Nigel Girgrah, Viviana Figueroa Diaz, Parvez Mantry, Mary Rinella, Amon Asgharpour, Douglas Dieterich. An algorithm for the management of non-alcoholic fatty liver disease in primary care. Gastroenterology & Hepatology: Open Access 2021; 12(4): 114 doi: 10.15406/ghoa.2021.12.00469
|
| 7 |
Stefano Bellentani. The epidemiology of non‐alcoholic fatty liver disease. Liver International 2017; 37(S1): 81 doi: 10.1111/liv.13299
|
| 8 |
Kira Bettermann, Tabea Hohensee, Johannes Haybaeck. Steatosis and Steatohepatitis: Complex Disorders. International Journal of Molecular Sciences 2014; 15(6): 9924 doi: 10.3390/ijms15069924
|
| 9 |
Jia Xiao, George L. Tipoe. Lycium Barbarum and Human Health. 2015; : 45 doi: 10.1007/978-94-017-9658-3_3
|
| 10 |
Mehmet Sayiner, Aaron Koenig, Linda Henry, Zobair M. Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clinics in Liver Disease 2016; 20(2): 205 doi: 10.1016/j.cld.2015.10.001
|
| 11 |
Gabriela S. de Castro, Philip C. Calder. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clinical Nutrition 2018; 37(1): 37 doi: 10.1016/j.clnu.2017.01.006
|
| 12 |
Yuri Hirayama, Natasha Faye Daniels, Shelley Evans, David Clarke, Stephenie Purvis, Charlotte Oliver, Stephen Woodmansey, Joy Staniforth, Elizabeth J. Soilleux. High Prevalence of Pre-Existing Liver Abnormalities Identified Via Autopsies in COVID-19: Identification of a New Silent Risk Factor?. Diagnostics 2021; 11(9): 1703 doi: 10.3390/diagnostics11091703
|
| 13 |
Soo Lim, Tae Jung Oh, Kwang Kon Koh. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. International Journal of Cardiology 2015; 201: 408 doi: 10.1016/j.ijcard.2015.08.107
|
| 14 |
Eirini Siafi, Ioannis Andrikou, Dimitris Konstantinidis, Niki Kakouri, Panagiotis Iliakis, John Koskinas, Emmanouil Koullias, Eleftherios Thireos, Dimitris Tousoulis, Costas Thomopoulos, Costas Tsioufis. Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus. Journal of Hypertension 2021; 39(12): 2470 doi: 10.1097/HJH.0000000000002954
|
| 15 |
Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, Philipp Pimingstorfer, Silke Suesse, Thomas-Matthias Scherzer, Bernhard Paulweber, Peter Ferenci, Thomas Stimpfl, Michel Yegles, Christian Datz, Michael Trauner. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease. Journal of Hepatology 2022; 77(4): 918 doi: 10.1016/j.jhep.2022.04.040
|
| 16 |
Zobair M. Younossi. Non-alcoholic fatty liver disease – A global public health perspective. Journal of Hepatology 2019; 70(3): 531 doi: 10.1016/j.jhep.2018.10.033
|
| 17 |
G. Vernon, A. Baranova, Z. M. Younossi. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics 2011; 34(3): 274 doi: 10.1111/j.1365-2036.2011.04724.x
|
| 18 |
Filippo Procino, Giovanni Misciagna, Nicola Veronese, Maria G. Caruso, Marisa Chiloiro, Anna M. Cisternino, Maria Notarnicola, Caterina Bonfiglio, Irene Bruno, Claudia Buongiorno, Angelo Campanella, Valentina Deflorio, Isabella Franco, Rocco Guerra, Carla M. Leone, Antonella Mirizzi, Alessandro Nitti, Alberto R. Osella. Reducing NAFLD‐screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans. Liver International 2019; 39(1): 187 doi: 10.1111/liv.13970
|
| 19 |
Noa Mashav, Oren Shibolet. Liver Metabolism and Fatty Liver Disease. Oxidative Stress and Disease 2014; 20144564: 3 doi: 10.1201/b17315-3
|
| 20 |
Eline H. van den Berg, Marzyeh Amini, Tim C. M. A. Schreuder, Robin P. F. Dullaart, Klaas Nico Faber, Behrooz Z. Alizadeh, Hans Blokzijl, Salvatore Petta. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort. PLOS ONE 2017; 12(2): e0171502 doi: 10.1371/journal.pone.0171502
|
| 21 |
Stergios A. Polyzos, Jannis Kountouras, Athanasios Papatheodorou, Kalliopi Patsiaoura, Evangelia Katsiki, Efthimia Zafeiriadou, Christos Zavos, Kyriaki Anastasiadou, Evangelos Terpos. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 2013; 62(1): 121 doi: 10.1016/j.metabol.2012.06.007
|
| 22 |
Christopher M. Milroy. Fatty Liver and the Forensic Pathologist. Academic Forensic Pathology 2018; 8(2): 296 doi: 10.1177/1925362118782061
|
| 23 |
Paulo Reis-Júnior, Ryan Tanigawa, Gustavo Heluani Antunes de Mesquita, Natalia Basan, Venâncio Alves, Luiz Augusto Carneiro D'Albuquerque, Wellington Andraus. Steatosis and steatohepatitis found in adults after death due to non-burn trauma. Clinics 2019; 74: e1070 doi: 10.6061/clinics/2019/e1070
|
| 24 |
Pedro M. Rodrigues, Ainhoa Lapitz, André L. Simão, Maria J. Perugorria, Marco Arrese, Rui E. Castro, Jesus M. Banales. NAFLD and NASH. 2020; : 157 doi: 10.1007/978-3-030-37173-9_9
|
| 25 |
Süleyman GÜNAY, Zehra Betül PAKÖZ, Haydar ADANIR. Evaluation of C-reactive protein levels in the differentiation of non-alcoholic steatohepatitis and simple liver steatosis. Akdeniz Medical Journal 2022; : 202 doi: 10.53394/akd.976570
|
| 26 |
Zaki A. Sherif, Armana Saeed, Shima Ghavimi, Seyed-Mehdi Nouraie, Adeyinka O. Laiyemo, Hassan Brim, Hassan Ashktorab. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations. Digestive Diseases and Sciences 2016; 61(5): 1214 doi: 10.1007/s10620-016-4143-0
|
| 27 |
Sim Y. Ong, Amanda J. Nicoll, Martin B. Delatycki. How should hyperferritinaemia be investigated and managed?. European Journal of Internal Medicine 2016; 33: 21 doi: 10.1016/j.ejim.2016.05.014
|
| 28 |
Kiran Gangadhar, Kedar N. Chintapalli, Gilbert Cortez, Sandhya Vinu Nair. MRI evaluation of fatty liver in day to day practice: Quantitative and qualitative methods. The Egyptian Journal of Radiology and Nuclear Medicine 2014; 45(3): 619 doi: 10.1016/j.ejrnm.2014.05.015
|
| 29 |
Linda Henry, James Paik, Zobair M. Younossi. Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world. Alimentary Pharmacology & Therapeutics 2022; 56(6): 942 doi: 10.1111/apt.17158
|
| 30 |
Bo Kyung Koo, Soo Lim. Clinical Obesity in Adults and Children. 2022; : 159 doi: 10.1002/9781119695257.ch13
|
| 31 |
Stergios A. Polyzos, Jannis Kountouras, Aristeidis Slavakis, Efthimia Zafeiriadou, Kalliopi Patsiaoura, Evangelia Katsiki, Christos Zavos, Athanasios Papatheodorou, Evangelos Terpos. A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study. Biomarkers 2013; 18(7): 607 doi: 10.3109/1354750X.2013.838305
|
| 32 |
Benedetta Campana, David Semela, Markus Heim, Christine Bernsmeier. Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?. EMJ Hepatology 2015; : 12 doi: 10.33590/emjhepatol/10314903
|
| 33 |
Abhijit Chowdhury, Zobair M. Younossi. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 21 doi: 10.1007/978-3-319-20538-0_2
|
| 34 |
Georgios Sfikas, Michael Psallas, Charalambos Koumaras, Konstantinos Imprialos, Evangelos Perdikakis, Michael Doumas, Olga Giouleme, Asterios Karagiannis, Vasilios G. Athyros. Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?. Current Vascular Pharmacology 2021; 19(5): 572 doi: 10.2174/1570161118666201015152921
|
| 35 |
Bubu A. Banini, Arun J. Sanyal. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clinical Medicine Insights: Therapeutics 2016; 8 doi: 10.4137/CMT.S18885
|
| 36 |
Shahid Habib. Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping. World Journal of Gastrointestinal Pathophysiology 2024; 15(2): 92791 doi: 10.4291/wjgp.v15.i2.92791
|
| 37 |
Martin Blachier, Henri Leleu, Markus Peck-Radosavljevic, Dominique-Charles Valla, Françoise Roudot-Thoraval. The burden of liver disease in Europe: A review of available epidemiological data. Journal of Hepatology 2013; 58(3): 593 doi: 10.1016/j.jhep.2012.12.005
|
| 38 |
Niki S. Kakouri, Costas G. Thomopoulos, Eirini P. Siafi, Angeliki E. Valatsou, Kyriakos S. Dimitriadis, Iliana P. Mani, Sotirios P. Patsilinakos, Dimitrios M. Tousoulis, Konstantinos P. Tsioufis. Overview of the Association between Non-Alcoholic Fatty Liver Disease and Hypertension. Cardiology Discovery 2023; doi: 10.1097/CD9.0000000000000113
|
| 39 |
Winston Dunn, Zhen Zeng, Maura O'Neil, Jie Zhao, Melissa Whitener, Yu-Jui Y Wan, Erik K Mitchell, Michael Handler, Steven A Weinman. The Interaction of rs738409, Obesity, and Alcohol: A Population-Based Autopsy Study. American Journal of Gastroenterology 2012; 107(11): 1668 doi: 10.1038/ajg.2012.285
|
| 40 |
Zobair Younossi, Quentin M. Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology 2018; 15(1): 11 doi: 10.1038/nrgastro.2017.109
|
| 41 |
Mark D. Muthiah, Arun J. Sanyal. Burden of Disease due to Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2020; 49(1): 1 doi: 10.1016/j.gtc.2019.09.007
|
| 42 |
Ilkay Ergenc, Erdogan Kara, Muhammed Emre Yilmaz, Coskun Ozer Demirtas, Caglayan Keklikkiran, Taner Das, Yalcin Buyuk, Cigdem Celikel, Hizir Asliyuksek, Yusuf Yilmaz. Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study. Heliyon 2024; 10(15): e34915 doi: 10.1016/j.heliyon.2024.e34915
|
| 43 |
Soo Lim, Marja‐Riitta Taskinen, Jan Borén. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obesity Reviews 2019; 20(4): 599 doi: 10.1111/obr.12820
|
| 44 |
Aitana Braza‐Boïls, Josep Marí‐Alexandre, Pilar Molina, Miguel A. Arnau, Moisés Barceló‐Molina, Diana Domingo, Javier Girbes, Juan Giner, Luis Martínez‐Dolz, Esther Zorio. Deregulated hepatic microRNAs underlie the association between non‐alcoholic fatty liver disease and coronary artery disease. Liver International 2016; 36(8): 1221 doi: 10.1111/liv.13097
|
| 45 |
Huilong Chen, Yuan Zhan, Jinxiang Zhang, Sheng Cheng, Yuhao Zhou, Liyuan Chen, Zhilin Zeng. The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019. JMIR Public Health and Surveillance 2022; 8(12): e34809 doi: 10.2196/34809
|
| 46 |
Soo Lim. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease. 2016; : 103 doi: 10.1002/9781118924938.ch12
|